The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout.
Yokose C, McCormick N, Abhishek A, Dalbeth N, Pascart T, Lioté F, Gaffo A, FitzGerald J, Terkeltaub R, Sise ME, Januzzi JL, Wexler DJ, Choi HK.
Yokose C, et al. Among authors: mccormick n.
Nat Rev Rheumatol. 2024 Apr;20(4):216-231. doi: 10.1038/s41584-024-01092-x. Epub 2024 Mar 12.
Nat Rev Rheumatol. 2024.
PMID: 38472344
Review.